Mandate

Vinge advises Skåne Dairy in connection with its sale of shares in ProViva AB to Danone and formation of a joint venture

September 29, 2010

Vinge has advised Skåne Dairy in connection with the sale of 51 per cent of the shares in ProViva AB to Danone. Pursuant to the terms of the agreement, the parties’ joint ownership of the company will commence at the end of 2010 and Danone will thereafter increase its stake in ProViva over the course of an 11-year period culminating in the company ultimately becoming wholly-owned by Danone. ProViva is a health drink containing a bacteria called Lactobacillus plantarum 299v, which was developed by Skåne Dairy in co-operation with Probi. The Danone Group is one of the world’s leading providers of fresh dairy products and its products include the Swedish registered brands Actimel, Activia and Danio.

Vinge’s team consisted of partner Björn Mullaart together with associates Kristian Ford, Anna Jonsson and Markus Larsson. Partner Ingela Malmborg and associate Therese Lindholm provided employment law advice and Ingela Malmborg together with associate Mathias Lindquist provided environmental law and permit compliance advice.

Related

Vinge advises parts of the consortium in connection with the public takeover offer for Cint

The public takeover offer was announced by a consortium consisting of Triton Fund 6, Bolero, Patrick Comer and Brett Schnittlich. The offer values all shares in Cint at approximately SEK 1,989 million. The shares in Cint are listed on Nasdaq Stockholm, Mid Cap.
April 27, 2026

Nordea and SEB enters into a SEK 2,000,000,000 credit facility agreement

On 22 April 2026, Nordea and SEB entered into a credit facility agreement in the aggregate amount of SEK 2,000,000,000 (with an accordion option for an additional SEK 400,000,000) with Humble Group AB (publ).
April 27, 2026

Vinge has advised Northmill in connection with its inaugural issuance of primary capital instruments (AT1)

Vinge has advised Northmill Group AB in connection with its issuance of SEK 275 million primary capital instruments (so called “AT1 bonds”) with a floating rate interest of 3-month STIBOR + 690 basis points. The AT1 bonds are perpetual with a first call option after five years and are intended to be admitted to trading on Nasdaq Transfer Market and, subsequently, on Nasdaq Stockholm.
April 27, 2026